SURVEY ON ANTIBIOTIC USE IN COVID-19 INPATIENTS AT NGUYEN TRI PHUONG HOSPITAL

Thị Hà Võ , Gia Hân Lý, Thu Thảo Vũ, Thu Thảo Nguyễn, Đức Chiến Võ

Main Article Content

Abstract

Objective: To evaluate antibiotic use of inpatients with COVID-19 at Nguyen Tri Phuong Hospital. Subjects and methods: Cross-sectional study, retrospective medical record of COVID-19 inpatients aged 18 years and older and assigned antibiotics in the period from July to October 2021. Chi-square test and binary logistic regression were used to determine the association between duration of antibiotic use and other variables. Results: Among 127 patients, severe COVID-10 cases accounted for 62.2%. Community-acquired pneumonia accounted for 100.0% and sepsis accounted for 9.4%. 41.7% of patients were tested for microbiology, of which, 40.8% were sampled before using antibiotics. The rate of positive electrocution accounted for 39.5% and there were only 7 cases of antibiogram (23.3%). The most common bacteria are Staphylococcus sp. (30.0%). The most common initial mono-, dual-, and triple- antibiotic therapy were ceftriaxone (50.0%), ceftriaxone + levofloxacin (65.7%), and meropenem + levofloxacin + vancomycin (28.6%). An inappropriate indication of antibiotics accounted for 7.0% and inappropriate antibiotic dose accounted for 11.0%. Patients who did not take concomitant antiretroviral drugs tended to have longer antibiotic therapy (OR = 0.137). Conclusion: The use of antibiotics in COVID-19 inpatients mostly followed treatment guidelines.

Article Details

References

1. Bộ Y tế (2015), Quyết định số 708/QĐ-BYT ngày 02 tháng 03 năm 2015 của Bộ Y tế về Tài liệu hướng dẫn sử dụng Kháng sinh, Hà Nội.
2. Bộ Y tế (2021), Quyết định số 4689/QĐ-BYT ngày 06 tháng 10 năm 2021 ban hành Hướng dẫn chẩn đoán và điều trị COVID-19, Hà Nội.
3. Bộ Y tế (2021), Bản tin cập nhật COVID-19 tính đến 06h00 ngày 19/7/2021, truy cập ngày 28/12/2022 tại trang web https://vncdc.gov.vn/ ban-tin-cap-nhat-covid-19-tinh-den-06h00-ngay-1972021-nd16288.html
4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507-513.
5. He Y, Li W, Wang Z, Chen H, Tian L, Liu D (2020) Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. Infect Control Hosp Epidemiol 41(8):982-983.
6. Mohamad IN, Wong CK, Chew CC, Leong EL, Lee BH, Moh CK, Chenasammy K, Lim SC, Ker HB (2022) The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective. J Pharm Policy Pract 15(1):4.
7. Seaton RA, Gibbons CL, Cooper L, Malcolm W, McKinney R, Dundas S, Griffith D, Jeffreys D, Hamilton K, Choo-Kang B, Brittain S, Guthrie D, Sneddon J (2020) Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect 81(6):952-960.